| 1-κB⍺ | I kappaB alpha |
| 4-OHT | 4-hydroxytamoxifen |
| 5-FU | 5-fluorouracil |
| AMPK | AMP-activated protein kinase |
| APCs | Antigen-presenting cells |
| ATF4 | Activating transcription factor 4 |
| β-carotene | Beta-carotene |
| Bax | Bcl-2-associated X protein |
| Bcl | B-cell lymphoma |
| Bid | BH3-interacting domain death agonist |
| Ca2+ | Calcium |
| ccRCC | Clear cell renal cell carcinoma |
| CDK | Cyclin-dependent kinase |
| CHOP | C/EBP homologous protein |
| CML | Chronic myeloid leukaemia |
| CRC | Colorectal cancer |
| CRT | Calreticulin |
| CSCs | Cancer stem cells |
| CTL | Cytotoxic T lymphocytes |
| DAMPs | Damage-associated molecular patterns |
| DC | Dendritic cells |
| DISC | Death-inducing signalling complex |
| DNases | Deoxyribonucleases |
| DR | Death receptor |
| DX | Doxorubicin |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| ER | Endoplasmic reticulum |
| ER+ | Oestrogen receptor–positive |
| ER− | Oestrogen receptor–negative |
| ERK | Extracellular signal-regulated kinase |
| ESCC | Oesophageal squamous cell carcinoma |
| ESM1 | Endothelial cell specific molecule 1 |
| FADD | Fas-associated death domain |
| FASL | Fas ligand |
| Fe2+ | Ferrous iron |
| FPE | First-pass effect |
| GC | Gastric cancer |
| GOT-1 | Glutamic-oxaloacetic transaminase 1 |
| GPER | G protein-coupled oestrogen receptor |
| GRP78 | Glucose-regulated protein 78 |
| GSDME | Gasdermin E |
| GTPBP4 | Guanosine triphosphate binding protein 4 |
| HCC | Hepatocellular carcinoma |
| HDAC | Histone deacetylase |
| HIF-1α | Hypoxia-inducible factor 1-alpha |
| HMOX1 | Heme oxygenase 1 |
| HNSCC | Head and neck squamous cell carcinomas |
| HPLC | High-performance liquid chromatography |
| HSCCC | High-speed counter-current chromatography |
| ICD | Immunogenic cell death |
| IHC | Immunohistochemistry |
| IR | Ionising radiation |
| IV | Intravenous |
| JNK | c-Jun N-terminal kinase |
| KM | Kunming |
| KRAS | Kirsten rat sarcoma virus |
| lncRNAs | Long non-coding RNAs |
| MAE | Microwave-assisted extraction |
| MAPK | Mitogen-activated protein kinase |
| MitoROS | Mitochondrial ROS |
| MLKL | Mixed lineage kinase domain-like protein |
| MM | Multiple myeloma |
| MMP | Mitochondrial membrane potential |
| MMP-2 | Matrix metalloproteinase-2 |
| MMP-9 | Matrix metalloproteinase-9 |
| MS | Murashige and Skoog |
| NF-κB | Nuclear factor kappa B |
| NHE1 | Sodium–hydrogen exchanger 1 |
| NSCLC | Non-small cell lung cancer |
| OSCC | Oral squamous cell carcinoma |
| OXA | Oxaliplatin |
| PAK1 | p21-activated kinase 1 |
| PAMPs | Pathogen-associated molecular patterns |
| PARP | Poly (ADP-ribose) polymerase |
| PBMC | Patient peripheral blood mononuclear cell |
| PCD | Programmed cell death |
| PDK1 | Pyruvate dehydrogenase kinase 1 |
| PFKFB2 | 6-phosphofruto-2-kinase/fructose-2,6-biphosphate |
| PHD3 | Prolyl hydroxylase 3 |
| PKM2 | Pyruvate kinase isoform M2 |
| PTEN | Phosphatase and tensin homologue |
| PUMA | p53 upregulated modulator of apoptosis |
| PYCR1 | Pyrroline-5-carboxylate reductase 1 |
| rhApo2L/TRAIL | Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand |
| RIPK1 | Receptor-interacting protein kinase1 |
| RIPK3 | Receptor-interacting protein kinase3 |
| ROS | Reactive oxygen species |
| RT-PCR | Real-time polymerase chain reaction |
| SC-CO2 | Supercritical carbon dioxide |
| SCLC | Small cell lung cancer |
| SD | Sprague Dawley |
| STP | Sarcoma-targeting-peptide |
| TAM | Tamoxifen |
| TCM | Traditional Chinese Medicine |
| TGF-β | Transforming growth factor β |
| TIME | Tumour immune microenvironment |
| TLRs | Toll-like receptors |
| TME | Tumour microenvironment |
| TNBC | Triple negative breast cancer |
| TNFα | Tumour necrosis factor-α |
| TRAP1 | Tumour necrosis factor receptor-associated protein 1 |
| Tregs | Regulatory T Cells |
| TrxR1 | Thioredoxin reductase 1 |
| UAE | Ultrasonic-assisted extraction |
| XBP-1 | X-box binding protein 1 |
| Zn-SHK-PEG | Zinc-shikonin-polyethylene glycol |